title: Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin.
abstract: It has been suggested that prevention and treatment of osteomyelitis could be achieved through local drug delivery using implantable devices, which provide therapeutic levels at the infection site with minimum side-effects. Physical blends of polycaprolactone (PCL) and poloxamine (Tetronic®) were prepared by applying a solvent-free hot melting approach to obtain cytocompatible implants with a tunable bioerosion rate, ciprofloxacin release profile and osteoconductive features. Differential scanning calorimetry and X-ray analysis indicate that the hydrophilic poloxamine varieties T908, T1107, and T1307 are miscible with PCL, while the hydrophobic block copolymer T1301 is immiscible. Incorporation of the block copolymer at weight ratios ranging from 25 to 75 wt.% led to matrices with viscoelastic parameters in the range of those of fresh cortical bone. Once immersed in buffer the matrices underwent a similar weight loss in the first week to the content of poloxamine, followed by a slower erosion rate due to PCL. The initial rapid erosion and the increase in porosity partially explain the observed burst of ciprofloxacin release, which is more intense in the PCL:T1301 formulation due to drug/T1301 repulsion due to polarity. The matrices sustained ciprofloxacin release for several months (<50% released after 3 months) and showed in vitro efficacy against Staphylococcus aureus, eradicating the bacteria in less than 48 h. PCL:poloxamine was cytocompatible with osteoblasts and the matrices prepared with low proportions of T908 were also compatible with mesenchymal stem cell differentiation to osteoblasts. The influence of the nature and proportion of temperature-responsive poloxamine on the performance of PCL implantable systems was determined.
authors.affiliation: Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Santiago de Compostela, 15782-Santiago de Compostela, Spain.
authors.forename: Ana M
authors.initials: AM
authors.lastname: Puga
authors.forename: Ana
authors.initials: A
authors.lastname: Rey-Rico
authors.forename: Beatriz
authors.initials: B
authors.lastname: Magariños
authors.forename: Carmen
authors.initials: C
authors.lastname: Alvarez-Lorenzo
authors.forename: Angel
authors.initials: A
authors.lastname: Concheiro
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000880:Anthraquinones / Q000378:metabolism; D002152:Calorimetry, Differential Scanning; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002939:Ciprofloxacin / Q000494:pharmacology*; D003460:Crystallization; D003692:Delayed-Action Preparations; D055119:Elastic Modulus / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D020007:Implants, Experimental; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D008826:Microbial Sensitivity Tests; D018613:Microscopy, Confocal; D008970:Molecular Weight; D016348:Osseointegration / Q000187:drug effects; D011091:Polyesters / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D016062:Porosity / Q000187:drug effects; D013194:Staining and Labeling; D044366:Transition Temperature; D014783:Viscosity / Q000187:drug effects
chemical_list: D000880:Anthraquinones; D003692:Delayed-Action Preparations; D011091:Polyesters; C016240:polycaprolactone; D011092:Polyethylene Glycols; D002939:Ciprofloxacin; C010078:alizarin; D000469:Alkaline Phosphatase